HEALTHeLINK, the innovative Buffalo-based HIE, announces a groundbreaking collaborative partnership with two new technology providers.
August 20, 2019 - Buffalo, NY: Clinithink and Stella Technology’s solutions are to be put to task sifting through HEALTHeLINK’s HIE data to identify patients at-risk for non-alcoholic fatty liver disease (NAFLD). The resulting data will be compared, contrasted and ultimately combined, enabling HEALTHeLINK to identify exciting new ways of offering advanced analytics to physicians - exactly where and when those analytics are needed - for better, and more efficient, patient care.
As the regional health information organization for Western New York, HEALTHeLINK has been working for over 10 years to connect hospitals, laboratories, radiology practices and participating provider organizations to exchange clinical information.
Dan Porreca, executive director of HEALTHeLINK explained “Leveraging and accurately analyzing HIE data for the benefit of patients has been a consistent focus for us. We are always looking for innovative ways to build on our current capabilities to help our patients and physicians avoid gaps in care, find and treat undiagnosed diseases, and ultimately improve the quality (and lower the cost) of health care.”
Clinithink, a supplier of artificial intelligence and CNLP solutions, were chosen by HEALTHeLINK for their ability to harvest the information-rich unstructured clinical narrative of the electronic medical record (found within the typed or dictated patient stories recorded by physicians and nurses such as progress notes, operative reports, discharge summaries, radiology reports and referral letters).
Clinithink’s platform reads all these documents at a rate of over one million per hour, encoding all the clinical concepts within them using post-coordinated SNOMED Clinical Terminology, and filtering the data output for the targeted therapeutic area (in this case those patients that meet the criteria for being at-risk for NAFLD).
As Clinithink’s AI/CNLP is advanced enough to understand negation in all its forms, understand the subtle differences between patient information and family history information, and understand severity levels and temporality, it is also able to eliminate false positives, making data more robust and therefore ultimately more able to improve patient care.
Stella Technology, a solution provider with deep expertise in clinical data and information exchange, was chosen by HEALTHeLINK for their ability to quickly and efficiently identify the patients with certain conditions within hundreds of structured database fields.
By using multi-step search criteria the Stella Prism platform, which was designed with flexibility and scalability at its core, enables search across numerous non-uniform health records from dozens of different sites and source systems. Following a “no data left behind” strategy, Prism allows healthcare organizations to find key insights from their complete data set within seconds (as opposed to the hours this search can take with more traditional analytics solutions).
Lalo Valdez, CEO of Stella, said “HEALTHeLINK is a great test bed for us because they have been so successful in establishing a connected infrastructure that has gathered 10 years of clinical reports from numerous hospitals and practices, adding up to many terabytes of rich clinical data. We very much look forward to helping find and analyze data for this study, which is exactly what Prism was designed to do.”
Glenn Keet, general manager of Clinithink, added “We are grateful to Dan Porecca and his team at HEALTHeLINK for including Clinithink in this exciting analysis opportunity, and we very much look forward to helping further define the future of HIE analytics alongside one of the most important HIEs in the world.”
For further information on Clinithink’s partnership with HEALTHeLINK please contact Glenn Keet
About HEALTHeLINK:
HEALTHeLINK is a collaboration among hospitals, physicians, health plans and other health care providers in the eight counties of western New York State to securely exchange clinical information to improve the quality of care, enhance patient safety and mitigate health care costs. HEALTHeLINK is a Qualified Entity of the Statewide Health Information Network for New York (SHIN-NY), which enables providers to access their patients’ data from across the state. HEALTHeLINK is also a founding member of the Strategic Health Information Exchange Collaborative (SHIEC), the national trade association of health information exchanges. Providers and patients can visit wnyhealthelink.com or @HEALTHeLINK on both Facebook and Twitter for more information.
About Clinithink:
Clinithink’s platform delivers the deepest, fastest and most accurate analysis of unstructured data across patient populations currently possible. This analysis provides medical professionals with the knowledge they need to quickly and accurately diagnose conditions and plan the most effective treatments. It enables our healthcare partners to provide optimal care to patients that is swiftly reimbursed, protecting their ability to deliver care to the people who need it most. And it can also fast forward drug development; ensuring protocols are optimized, patients matched and sites identified in a fraction of the time of manual processing – helping our life science associates get the treatments patients need to market faster. For further information visit www.clinithink.com
About Stella Technology:
In an increasingly vast and complex world of Health Information, Stella Technology’s team and solutions enable healthcare organizations to harness the power of their data to deliver more efficient and effective healthcare services. With accurate and high quality data as a foundational tenet of its advanced big data analytics capabilities, the Stella Prism platform unifies data silos to reveal powerful insights – clinical, administrative, operational – that are difficult to uncover with traditional analytics solutions. For more information, please visit stellatechnology.com or contact us at info@stellatechnology.com.